These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 31928220

  • 1. Interaction of epidermal growth factor with COX-2 products and peroxisome proliferator-activated receptor-γ system in experimental rat Barrett's esophagus.
    Majka J, Wierdak M, Szlachcic A, Magierowski M, Targosz A, Urbanczyk K, Krzysiek-Maczka G, Ptak-Belowska A, Bakalarz D, Magierowska K, Chmura A, Brzozowski T.
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar 01; 318(3):G375-G389. PubMed ID: 31928220
    [Abstract] [Full Text] [Related]

  • 2. Cyclooxygenase-2 (COX-2) is the key event in pathophysiology of Barrett's esophagus. Lesson from experimental animal model and human subjects.
    Majka J, Rembiasz K, Migaczewski M, Budzynski A, Ptak-Belowska A, Pabianczyk R, Urbanczyk K, Zub-Pokrowiecka A, Matlok M, Brzozowski T.
    J Physiol Pharmacol; 2010 Aug 01; 61(4):409-18. PubMed ID: 20814068
    [Abstract] [Full Text] [Related]

  • 3. Esophagoprotective activity of angiotensin-(1-7) in experimental model of acute reflux esophagitis. Evidence for the role of nitric oxide, sensory nerves, hypoxia-inducible factor-1alpha and proinflammatory cytokines.
    Pawlik MW, Kwiecien S, Pajdo R, Ptak-Belowska A, Brzozowski B, Krzysiek-Maczka G, Strzalka M, Konturek SJ, Brzozowski T.
    J Physiol Pharmacol; 2014 Dec 01; 65(6):809-22. PubMed ID: 25554985
    [Abstract] [Full Text] [Related]

  • 4. Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines.
    Pawlik M, Pajdo R, Kwiecien S, Ptak-Belowska A, Sliwowski Z, Mazurkiewicz-Janik M, Konturek SJ, Pawlik WW, Brzozowski T.
    J Physiol Pharmacol; 2011 Feb 01; 62(1):75-86. PubMed ID: 21451212
    [Abstract] [Full Text] [Related]

  • 5. Indomethacin but not a selective cyclooxygenase-2 inhibitor inhibits esophageal adenocarcinogenesis in rats.
    Esquivias P, Morandeira A, Escartín A, Cebrián C, Santander S, Esteva F, García-González MA, Ortego J, Lanas A, Piazuelo E.
    World J Gastroenterol; 2012 Sep 21; 18(35):4866-74. PubMed ID: 23002358
    [Abstract] [Full Text] [Related]

  • 6. Agonist of peroxisome proliferator-activated receptor gamma (PPAR-gamma): a new compound with potent gastroprotective and ulcer healing properties.
    Brzozowski T, Konturek PC, Pajdo R, Kwiecień SN, Konturek S, Targosz A, Burnat G, Cieszkowski J, Pawlik WW, Hahn EG.
    Inflammopharmacology; 2005 Sep 21; 13(1-3):317-30. PubMed ID: 16259750
    [Abstract] [Full Text] [Related]

  • 7. Lack of Association between Epidermal Growth Factor or Its Receptor and Reflux Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma: A Case-Control Study.
    Deissova T, Cvanova M, Kala Z, Jiraskova Zakostelska Z, Dolina J, Kunovsky L, Kroupa R, Pavlovsky Z, Lipovy B, Danek Z, Izakovicova Holla L, Urban O, Navratil V, Lischke R, Harustiak T, Grolich T, Prochazka V, Slaby O, Borilova Linhartova P.
    Dis Markers; 2022 Sep 21; 2022():8790748. PubMed ID: 36092955
    [Abstract] [Full Text] [Related]

  • 8. Cyclooxygenase-2 and inflammation mediators have a crucial role in reflux-related esophageal histological changes and Barrett's esophagus.
    Taddei A, Fabbroni V, Pini A, Lucarini L, Ringressi MN, Fantappiè O, Bani D, Messerini L, Masini E, Bechi P.
    Dig Dis Sci; 2014 May 21; 59(5):949-57. PubMed ID: 24357184
    [Abstract] [Full Text] [Related]

  • 9. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM, Abdel-latif MM, Ravi N, McNamara D, Byrne PJ, McDonald GS, Keeling PW, Kelleher D, Reynolds JV.
    Am J Gastroenterol; 2005 Jun 21; 100(6):1257-64. PubMed ID: 15929754
    [Abstract] [Full Text] [Related]

  • 10. Esophageal Helicobacter pylori colonization aggravates esophageal injury caused by reflux.
    Chu YX, Wang WH, Dai Y, Teng GG, Wang SJ.
    World J Gastroenterol; 2014 Nov 14; 20(42):15715-26. PubMed ID: 25400455
    [Abstract] [Full Text] [Related]

  • 11. Pioglitazone, a specific ligand of the peroxisome proliferator-activated receptor gamma reduces gastric mucosal injury induced by ischaemia/ reperfusion in rat.
    Konturek PC, Brzozowski T, Kania J, Kukharsky V, Bazela K, Kwiecien S, Harsch I, Konturek SJ, Hahn EG.
    Scand J Gastroenterol; 2003 May 14; 38(5):468-76. PubMed ID: 12795455
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In Barrett's epithelial cells, weakly acidic bile salt solutions cause oxidative DNA damage with response and repair mediated by p38.
    Huo X, Dunbar KB, Zhang X, Zhang Q, Spechler SJ, Souza RF.
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar 01; 318(3):G464-G478. PubMed ID: 31984785
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of PPARgamma activation by the oral antidiabetic agent pioglitazone in Barrett's carcinoma in vitro and in vivo.
    Al-Taie OH, Graf T, Illert B, Katzenberger T, Mörk H, Kraus MR, Barthelmes HU, Scheurlen M, Seufert J.
    J Gastroenterol; 2009 Mar 01; 44(9):919-29. PubMed ID: 19506796
    [Abstract] [Full Text] [Related]

  • 15. Role of the EGF receptor in PPARγ-mediated sodium and water transport in human proximal tubule cells.
    Saad S, Zhang J, Yong R, Yaghobian D, Wong MG, Kelly DJ, Chen XM, Pollock CA.
    Diabetologia; 2013 May 01; 56(5):1174-82. PubMed ID: 23370527
    [Abstract] [Full Text] [Related]

  • 16. Peroxisome proliferator-activated receptor-γ activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress.
    Martín A, Pérez-Girón JV, Hernanz R, Palacios R, Briones AM, Fortuño A, Zalba G, Salaices M, Alonso MJ.
    J Hypertens; 2012 Feb 01; 30(2):315-26. PubMed ID: 22179086
    [Abstract] [Full Text] [Related]

  • 17. Activation of NFkappaB represents the central event in the neoplastic progression associated with Barrett's esophagus: a possible link to the inflammation and overexpression of COX-2, PPARgamma and growth factors.
    Konturek PC, Nikiforuk A, Kania J, Raithel M, Hahn EG, Mühldorfer S.
    Dig Dis Sci; 2004 Aug 01; 49(7-8):1075-83. PubMed ID: 15387324
    [Abstract] [Full Text] [Related]

  • 18. Reflux esophagitis and its role in the pathogenesis of Barrett's metaplasia.
    Souza RF.
    J Gastroenterol; 2017 Jul 01; 52(7):767-776. PubMed ID: 28451845
    [Abstract] [Full Text] [Related]

  • 19. Activation of peroxisome proliferator-activated receptor-gamma by curcumin blocks the signaling pathways for PDGF and EGF in hepatic stellate cells.
    Lin J, Chen A.
    Lab Invest; 2008 May 01; 88(5):529-40. PubMed ID: 18332871
    [Abstract] [Full Text] [Related]

  • 20. Cancer-related inflammation and Barrett's carcinogenesis: interleukin-6 and STAT3 mediate apoptotic resistance in transformed Barrett's cells.
    Zhang HY, Zhang Q, Zhang X, Yu C, Huo X, Cheng E, Wang DH, Spechler SJ, Souza RF.
    Am J Physiol Gastrointest Liver Physiol; 2011 Mar 01; 300(3):G454-60. PubMed ID: 21148399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.